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Background: The generation of interferon-gamma (IFN-γ) by MHC class II activated CD4+ T helper cells play a
substantial contribution in the control of infections such as caused by Mycobacterium tuberculosis. In the past,
numerous methods have been developed for predicting MHC class II binders that can activate T-helper cells. Best
of author’s knowledge, no method has been developed so far that can predict the type of cytokine will be secreted
by these MHC Class II binders or T-helper epitopes. In this study, an attempt has been made to predict the IFN-γ
inducing peptides. The main dataset used in this study contains 3705 IFN-γ inducing and 6728 non-IFN-γ inducing
MHC class II binders. Another dataset called IFNgOnly contains 4483 IFN-γ inducing epitopes and 2160 epitopes that
induce other cytokine except IFN-γ. In addition we have alternate dataset that contains IFN-γ inducing and equal
number of random peptides.
Results: It was observed that the peptide length, positional conservation of residues and amino acid composition
affects IFN-γ inducing capabilities of these peptides. We identified the motifs in IFN-γ inducing binders/peptides
using MERCI software. Our analysis indicates that IFN-γ inducing and non-inducing peptides can be discriminated
using above features. We developed models for predicting IFN-γ inducing peptides using various approaches like
machine learning technique, motifs-based search, and hybrid approach. Our best model based on the hybrid
approach achieved maximum prediction accuracy of 82.10% with MCC of 0.62 on main dataset. We also developed
hybrid model on IFNgOnly dataset and achieved maximum accuracy of 81.39% with 0.57 MCC.
Conclusion: Based on this study, we have developed a webserver for predicting i) IFN-γ inducing peptides, ii)
virtual screening of peptide libraries and iii) identification of IFN-γ inducing regions in antigen (http://crdd.osdd.net/
raghava/ifnepitope/).
Reviewers: This article was reviewed by Prof Kurt Blaser, Prof Laurence Eisenlohr and Dr Manabu Sugai.Background
The present vaccination strategies are contemplating
subunit vaccine as an alternative to traditional attenu-
ation approach. These subunit vaccines consist of a part
of the pathogen to be used as vaccine, which generally
include the peptides or proteins [1,2]. This novel strategy
of vaccination has motivated the research towards devel-
opment of subunit vaccines to combat a number of dis-
eases like tuberculosis, malaria, anthrax, cancer and
swine fever [3-7]. The major challenge in designing
subunit vaccine is identification of antigenic regions
(peptides or proteins) in the pathogen proteome that
can induce desired immune response in the host* Correspondence: raghava@imtech.res.in
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Chandigarh 160036, India
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reproduction in any medium, provided the ororganism, mainly human. Ideally one should experimen-
tally check immune response for each possible fragment/
peptide of pathogen proteome. In practice, it is not
possible due to two reasons i) possible fragments are in
the range of millions and ii) experimental techniques are
costly and time consuming [8-11]. There is a need to
assist experimental scientist using alternate approaches
like computational techniques.
There is a tremendous change in the field of immun-
ology in last few years due to exponential growth of new
field immunoinformatics or computational immunology.
In the last decade, numerous software, databases and
web servers have been developed to identify antigenic
regions that can activate various arms of the immune
system like humoral, cellular and innate immunity.
Broadly these in silico tools can be divided in followingl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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activating humoral response, ii) MHC class I/II binders,
TAP binders, protease cleavage for understanding cell
mediated immunity and iii) pathogen associated molecu-
lar patterns for activating innate immunity [12-40].
Identification of antigenic regions that bind MHC class
II and activate T-helper cells are crucial for designing
subunit vaccine. As activated T-helper cells release cyto-
kines that activate cytotoxic T-cell and B-cells. There are
different types of T-helper cells (e.g., Th1, Th2, Th17,
iTregs) and each type of helper cell secrete specific type
of cytokine [41-44] (Figure 1). For example, Th1 cells re-
lease IFN-γ and activates macrophages that are required
to eradicate the intracellular pathogen like Mycobacter-
ium tuberculosis [45-48]. T cells, NK cells, and NKT cells
are the primary producers of IFN-γ, and it helps in fight-
ing against bacterial, viral and tumor growth by regulat-
ing immune system. In order to design subunit vaccine
or immunotherapy, one need to identify MHC class II
binders that can activate IFN-γ inducing T-helper cells.
In past numerous methods have been developed to
predict MHC class II binders that can activate T-helper
cells. Best of author’s knowledge no method has been
developed so far that can predict the type of T-helper
cells will be activated, or type of cytokine will be re-
leased. The role of epitopes in deciding the immune re-
sponse is well documented in literature [49-52]. In order
to design subunit vaccine with more precision, there is a
need to develop a method that can predict peptides that
can activate specific type of cytokine. In this study, first
time a systematic attempt has been made to predict
IFN-γ inducing MHC class II binders or peptides.Figure 1 The schematic representation of CD4+ T cell differentiationMethods
Datasets
Main dataset
We extracted 10,433 experimentally validated MHC
class II binders or T-helper epitopes from Immune Epi-
tope Database (IEDB) [53]. Out of these 10,433 MHC
class II binders, 3705 induced IFN-γ, whereas remaining
6728 unique peptides have not induced IFN-γ. Thus, our
dataset contains 3705 positive examples or IFN-γ indu-
cing peptides and 6728 negative examples or IFN-γ non-
inducing peptides.
IFNgOnly dataset
This dataset has been created to resolve the issue, if a
peptide is not inducing interferon-gamma, would it in-
duce other cytokine after binding with MHC class II?
The dataset was compiled from IEDB; we obtained 4483
MHC II binders or epitope that induce IFN-gamma only
and 2160 epitopes which induce cytokines other than
interferon-gamma. The numbers of IFN-γ inducing epi-
topes are greater in this dataset than our main dataset
due to updation of IEDB in the mean time. While creat-
ing this dataset, we have removed the redundant and the
epitopes which have induced two or more cytokines.
IFNrandom or alternate dataset
This is alternative dataset, where IFN-gamma inducing
epitope were taken positive examples and equal numbers
of peptides (3705) with same length variation from swis-
sprot were generated in random fashion for negative ex-
amples. The model developed on this dataset would be
very useful in discriminating the IFN-gamma inducinginto three principal subsets.
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tus is not known.
Analysis of length and positional conservation of
peptides
In order to understand the preference of length in posi-
tive and negative peptides, we used R-package for creat-
ing boxplot [54]. To understand position specific
preference of each residue, we used two-sample logo
software, where we created a two-sample logo from first
15 amino acids of N-terminal of complete peptides [55].
In this case, we removed all the peptides shorter than 15
residue length and remaining 89% peptides contained
2965 and 6336 peptides of positive and negative in-
stances, respectively. On the other hand, in IFNgOnly
dataset, there were 3682 epitopes in positive examples
and 1641 epitopes remained in negative examples after
applying the above filter.
Motif based approach
Identification of functional motifs in peptides or proteins
is extremely valuable in the field for functional annotation
of proteins/peptides [56]. In this study, we used a powerful
software called MERCI for searching exclusive motifs in
positive and negative examples [57]. Although, MERCI
uses positive and negative examples simultaneously as an
input but at a time it gives motifs for the positive examples
only. Therefore, we applied two-step strategy, where first
we used IFN-γ inducing peptides dataset as positive and
non-IFN-γ inducing peptide dataset as negative input and
extracted motifs for IFN-γ inducing examples. Conse-
quently, in order to extract motifs for the non-IFN-γ indu-
cing examples, we used IFN-γ inducing examples as
negative and IFN-γ non-inducing examples as positive in-
put. In this way, we extracted motifs for both IFN-γ indu-
cing and IFN-γ non-inducing examples. We have searched
100 degenerate motifs from the following three kinds of
classification: i) None, ii) Koolman-Rohm and iii) Betts-
Russell. The Betts-Russell classification could be further
divided in to 3 categories: i) Polar, ii) Hydrophobic and iii)
Small. These different classification methods produce
different motifs in the both positive and negative pep-
tides. Thus, we selected unique motif-containing pep-
tide from both datasets, in order to calculate overall
motif coverage in the dataset. The peptides of IFN-γ in-
ducing and IFN-γ non-inducing examples containing
positive and negative motifs were assigned as true posi-
tives and true negatives respectively.
Amino acid compositions
In-house Perl scripts were used to calculate the amino
acid composition, which encapsulate the intact epitope
information in a fixed vector length as required by ma-
chine learning algorithm. The amino acid composition(MPC) creates a vector of 20 properties for each epitope
using the following formula:
Compostition of amino acid ið Þ
¼ Total number of amino acid ið Þ  100
Total number of all amino acid in epitope
Where i can be any amino acid
Similarly, di-peptide composition (DPC) resulted in a
vector of 400 and was computed using the formula:
Compostitionof dipeptide iþ 1ð Þ
¼ Totalnumberof dipeptide iþ 1ð Þ  100
Totalnumberof allpossibledipeptides inepitope
Where i canbeany aminoacidand iþ 1ð Þ isdipeptide
pairwithnext residue inpeptide
Binary approach
We applied binary approach, in which positive and nega-
tive examples were converted into the binary patterns.
Each amino acid represented by an unique vector of 20 di-
mensions (e.g. Ala by 1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0;
Cys by 0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0) for different 20
standard amino acids. For example,15-residue long pep-
tide represented by the 300 (15 X 20) dimensions of a vec-
tor as an input.
Machine learning approach
In this study, SVM (Support Vector Machine) was ap-
plied for machine learning approach [58]. Based on the
features (amino acid composition and length) generated
above, the support vector machine was optimized at dif-
ferent parameters of various kernels (linear, sigmoidal
and radial basis function), and the best-optimized model
was selected for software implementation.
Hybrid approach
In the hybrid approach, we combined the predictions
from motif approach and machine learning approach.
First of all, the sequences were separated that could be
correctly predicted via motif based approach and the
remaining sequences were then predicted using SVM.
Various hybrid models were developed based on the type
of vector inputs used for SVM-based prediction. Finally,
the performance was evaluated by adding the truly pre-
dicted peptides from the motif-based method with SVM
based predictions.
Cross validation
To test the vigor of the model, it was evaluated with five
fold cross validation, where the complete dataset was di-
vided into five equal parts and out of these four parts
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used for testing. This process was repeated five times in
such a way that each part was once used for testing and
four times it was a part of training. The overall perfor-
mances were calculated by averaging the result of each
test. The best model was also validated on 10 fold cross
validation. In cross validation for hybrid approach, the
results of motifs were directly added in the five or ten
fold cross validation through SVM based approach.
Evaluation parameters
The performance of the model was evaluated in terms of
sensitivity, specificity, accuracy and MCC16. These pa-





Accuracy ¼ TPþ TN
TPþ FNþ TNþ FP 100
MCC ¼ TP TN‐FN FPﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPþ FNð Þ TPþ FPð Þ TNþ FPð Þ TNþ FNð Þp
TP = True Positive, FP = False Positive, TN = True
Negative, FN = False Negative.
Results
Examination of dataset
The peptides in the main dataset were obtained from
17,752 assays, where 5962 assays had shown to be posi-
tive for interferon-gamma secretion. These peptides
were derived from 281 source organisms and were pre-
sented through 153 MHC alleles from 181 different host
species/strains. On the other hand, the epitopes in IFN-
gOnly dataset were extracted from 15,778 assays. Out
of these 15,778 assays 7302 assays have induced IFN-
gamma and remaining 8476 assays have induced the se-
cretion of other cytokine except interferon-gamma. The
epitopes in IFNgOnly dataset were extracted from 394
different sources and presented through 183 MHC al-
leles in 232 host strains. The detailed analysis of epi-
topes with respect to MHC alleles, host strain and
source organisms is available in supplementary excel
sheet (Additional file 1).
Data analysis
We analyze IFN-γ inducing and non-inducing peptides
in main dataset to fish out the important features. It was
observed that the length of peptides plays a prominent
role in discriminating the IFN-γ inducing and non-
inducing peptides (Figure 2). As shown in Figure 2, ma-
jority of the negative peptides fall within the range of
15–16 amino acids while most of the positive peptide
have wide distribution from 13 to 22 residues. It can bedeciphered from the boxplot (Figure 3) that the IFN-γ
inducing and non-inducing peptides prefer different
lengths. The whiskers of the boxplot denote the range of
distribution that varies from 8 to 27 residues length in
positive dataset while negative data clumped only at the
residues length of 15. The green colored area in the box
could be inferred as the skewness of the positive dataset
toward the length more than 15 amino acid residues
which means IFN-γ inducing dataset has significant pep-
tides with length more than 15 amino acid residues. No
data skewness was observed in IFN-γ non-inducing sam-
ples. We did not find any difference in length of peptides
inducing IFN-γ from the peptides that have induced any
other cytokine than IFN-γ present in our IFNgOnly
dataset (Figure 4).Composition analysis
We computed amino acid composition of peptides and
observed a significant difference in composition of cer-
tain residues in two types of peptides. In case of IFN-γ
inducing peptides A, E, G, P, Q, R residues are more
abundant, while residues C, L, S, T, I are more preferred
in negative peptides (Figure 5). On the other hand the
residues D, E, K and N are more abundant in IFN-γ in-
ducing dataset as compared to the residues L, V, R and
M are preferred for the induction of other cytokine than
IFN-γ as depicted from two-sample logo of IFNgOnly
dataset (Figure 6).Positional preference of residues
Compositional analysis provides only overall preference
of a residue but no information about preference of a
particular residue at a specific position in peptide. In
order to understand positional information of each resi-
due; we created a two-sample logo for our positive and
negative peptides. We observed that amino acids are
playing an important role in discriminating the IFN-γ in-
ducing and non-inducing peptides (Figure 7). Charged
residues are preferred in positive dataset at 4th, 9th, 10th
and 13th position, on the other hand aliphatic residues
are preferred at 4th, 5th, 9th, 11th and 12th position in
negative peptides. Additionally, polar uncharged residues
are prevalent at 2nd, 3rd and 14th position in IFN-γ indu-
cing instances. In case of peptides in IFNgOnly dataset,
it was observed that glutamine is preferred at first to
third position of IFN-γ inducing peptides while for the
induction of other cytokine positively charged residues
like H and R are preferred at these position (Figure 8). It
is also clear from the Figure 8 that negatively charged
residues are not preferred at any of position in IFN-γ in-
ducing peptides but in case of induction of rest of cyto-
kine negatively charged residues are prevalent at 4th, 6th,
8th, 11th and 13th position.
Figure 2 Bar graph showing length of peptide and their frequency in our main dataset.
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In order to discover exclusive patterns or motif in our pep-
tides, we used the MERCI software. We have used three
kinds of amino acid classification (None, Koolman-Rohm
and Betts-Russell) to discover the 100 motifs. We observed
that Betts-Russell classification under polar root could dis-
criminate the dataset most significantly with 532 positive
peptides and 1835 negative peptides. By combining all the
motifs from different classification, 964 positive and 2827
negative peptides could be discriminated [Table 1].
The top motifs from each classification are shown in
Table 2. The most significant motifs discovered is “[ali-
phatic]-I-[aliphatic]L[aliphatic][aliphatic][aliphatic]-[ali-
phatic]”, which was repeated in 89 negative peptides
and was absent in positive peptides. The most signifi-
cant motif in positive IFN-γ inducing dataset, that is
present in 53 positive sequences and none of the nega-
tive sequence, is “Q-[aliphatic]-[neutral]-P[neutral]-Q”.Figure 3 Boxplot to showing the length-wise distribution of both typ
in main dataset. The dots are representing the outliers; the dotted line reMERCI software compares positive and negative dataset
and motifs provided will be changed as we change the in-
put dataset. So in case of IFNgOnly dataset the best classifi-
cation is Betts-Russell under polar root for IFN-γ inducing
epitopes. It was observed that 37% of IFN-γ inducing
epitopes could be discriminated with this classification.
While for inducing rest of cytokine (except IFN-γ) best
discrimination was observed when no classification of
amino acid was used, where we can predict up to 384
epitopes (Table 3).
We have also extracted the best motifs for such distinc-
tion in each classification approach for our second dataset
“IFNgOnly” (Table 4) and found that “YR[aliphatic]” is the
best motif in IFN-gamma inducing epitopes to discrimin-
ate them from the epitope that have induced other cyto-
kine. This motif was present in 63 sequences. On the
other hand “PN[hydrophobic][small]-[positive]-[polar]”
was the most prevalent motif to distinguish epitopes thate of MHC II binders (IFN-γ inducing and non-inducing peptides)
presents to cover the data and strong line displays median.
Figure 4 Boxplot to represent the distribution of epitopes in IFNgOnly dataset. Here dots are outliers. Blue box is having IFN-γ epitopes
while green box comprises of the epitopes secreting rest of cytokine (except IFN-γ).
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with the coverage of 32 sequences.
Model based on machine learning technique
In this study, we developed Support Vector Machine
(SVM) based models, implemented using freely available
software SVMlight that is widely used in classificationFigure 5 Amino acid composition of both class of MHC class II binderproblems [21,59-61]. In this study, we developed SVM
based models using amino acid and dipeptide compos-
ition of peptides and achieved maximum MCC 0.33 and
0.49, respectively [Table 5]. It has been observed that
length of peptide play vital role in discriminating these
two types of peptides. Thus we also developed model
using amino acid and dipeptide composition of peptidess in main dataset.
Figure 6 Residue composition plot for IFNgOnly dataset.
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imum MCC 0.43 and 0.54, respectively. This clearly indi-
cates the role of length of peptides in discriminating two
types of peptides.
We have also built SVM models for IFNgOnly dataset
and attained maximum MCC 0.25 and 0.35 with resi-
due composition and dipeptide composition, respect-
ively (Table 6). The performance of our model was not
changed significantly when length was used as feature
with composition.
Additionally, we also developed SVM based models
using binary profile where each position is represented by
a vector of dimension of 20 (each element represent pres-
ence or absence of a specific type of residue). The perform-
ance of models developed using binary profile of N-/C-
terminal residues is shown in Additional file 2: Table S1
along with the composition variation plot for each residue
in Additional file 2: Figures SF1 and SF2.Figure 7 Two-sample logo of 15 N-terminal amino acids (first 15 residHybrid approach
The hybrid approach was applied to combine the predic-
tion using MERCI and SVM. In this approach, the dataset
were classified on the basis of exclusively motif search
using MERCI, where 964 IFN-γ inducing and 2827 IFN-γ
non-inducing MHC class II binders could be discrimi-
nated and the remaining 2741 positive and 3901 nega-
tive peptides were discriminated using SVM. In this
approach four different hybrid models were developed
with different input features. We observed that using
the hybrid approach the performance was increased in
each hybrid model. By this way, we achieved MCC
value up to 0.62 in combining dipeptide composition,
length and Merci motif search [Table 7]. The compara-
tive results were also plotted in threshold independent
manner using ROC plot (Figure 9). In order to check
the robustness of model, 10 fold cross validation was
performed on our best model and consistency in theues) in main dataset at a p value of <0.0001.
Figure 8 Representing the Two-sample logo from 15 N-terminal residues in IFNgOnly dataset at p value of <0.05.
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generated on 5 fold cross validation.
We have also developed the hybrid models for our
second dataset (IFNgOnly). Here the MERCI could dis-
criminate 3058 IFN-γ and 679 rest cytokine epitopes.
The remaining 1425 IFN-γ and 1485 rest cytokine epi-
topes were discriminated using SVM. The performance
of the hybrid model was 86.97%, 68.38%, 80.93% in
terms of sensitivity, specificity and accuracy [Table 8].
On the other hand, performance was slightly improved
with dipeptide composition feature. We also observed
adding length as an additional feature in residue com-
position or dipeptide composition did not improve the
performance [Table 8].
Models for discovering IFN-γ inducing peptides
All the models described above has been developed on
dataset that contain experimentally validated IFN-γ in-
ducing and non-inducing MHC class II binders. These
models only can be used for predicting IFN-γ inducing
peptides if users know that their query peptide is MHC
class II binders. In order to provide service to the com-
munity we developed models on alternate dataset “IFN-
random” (random negative dataset) that can be used to
discover IFN-γ peptides in proteins/antigens. As de-
scribed in materials and the methods section our alter-
nate dataset contain, negative set/examples are random
peptide. We developed models on alternate dataset and
achieved maximum accuracy of 73.4% and sensitivity of
69.18% (Table 9).Table 1 Exclusive motifs of different class found in IFN-γ









1 None 71 1045
2 Koolman-Rohm 148 624
3 Betts-Russell (Hydorphobic) 501 573
4 Betts-Russell (Polar) 532 1835
5 Betts-Russell (Small) 320 1133
6 ALL class 964 2827
These motifs were discovered using MERCI software.Discussion
In the era of computer aided vaccine design, researchers
are trying to find out the best epitope that can induce
desired immune response. To be the best vaccine candi-
date, a peptide should not only be epitope for B and T
cell, but it should also be able to evoke the desired type
of immune cells to generate the required response. For
example, in tuberculosis the vaccine candidate must be
able to induce IFN-γ to eradicate the infection [62-64].
Therefore, there is a need of a method, which could pre-
dict the peptide responsible for secreting IFN-γ. The
MHC-peptide complex may be exceptionally crucial for
deciding the type of transcription factors to be activated
after this association, which is responsible for the type of
cytokine released [65,66]. Therefore, the biasness of
MHC alleles and secretion of interferon-gamma were
analyzed. In case of main dataset, alleles were not deter-
mined for 10,767 assays out of 17,752 interferon gamma
assays; similarly in case of IFNgOnly dataset) alleles were
not determined for 6576 assays out of 15,778. Source or-
ganisms and host species/strains are also very important
in deciding the secretion of interferon gamma.
The binding affinity of these peptides with MHC was
shown to be dependent on the length of peptides [67].
Therefore we analyzed the length variation in our data-
sets. The variability in length was observed from 9 to 30
with some exceptions, which was in consistent with
previously reported by Nielsen et. al. in the analysis of
SYFPEITHI and MHCPEP [68-70]. The skewness in the
positive dataset was observed with length more than 15
amino acid residues. It has been reported that the pep-
tides having more than 15–16 amino acids showed less
affinity toward MHC class II, and this lesser affinity
might be creating an environment that lead to release
of IFN-gamma. We have also observed that length of
the peptide is not significantly different in IFN-γ, when
compared with length of peptides that have induced
other cytokine.
Besides length, the conservation of the residue at a spe-
cific position may also be beneficial. Therefore, we have
compared the positive and negative epitope data to fish
out the prime residue activating IFN-γ releasing potential.
In our observation, it was noticed that charged residues
Table 2 Frequency of best motifs discovered using MERCI software in IFN-γ epitopes and non-epitopes
Class of Motifs Found in IFN epitopes Frequency Found in non-epitopes Frequency
None QPQ-Q-P-Q 41 IS-L-M 40



















Negative sign (−) = represents the gaps at that position.
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the Leucine and Iso-leucine residues are dominating in
the peptides not inducing the release of IFN-γ. The differ-
ential preference may be significant for the different acti-
vation factors activated. While in case of comparison
between IFN-γ and rest of cytokine using IFNgOnly data-
set, it was observed that at position 4th, 9th and 10th
charged residue are more prevalent in IFN-γ inducing
peptides. This observation was in consensus with the ob-
servation from our main dataset. It was also found that
negatively charged residues are dominating for induction
of other cytokine except IFN-γ at 4th, 6th ,8th ,11th and
13th position. This kind of discrimination could be utilized
for designing Th1 inducing peptides based upon amino
acid properties.
The positional feature of a sequence could be encoded
in machine learning format by generating binary feature
input. This binary feature input could only be applied at a
fixed length pattern, therefore different binary inputs were
created by varying the length of amino acids from 9 to 15
through both N and C-terminal of a peptide. The per-
formance of SVM model on these input vectors was nearly
the same in terms of MCC. The compositional vector
amino acid and dipeptide for a sequence has fixed featureTable 3 Exclusive motifs of different class found in IFN-γ
inducing and other cytokine (except IFN-γ) inducing pep-










1 None 696 384
2 Koolman-Rohm 1481 219
3 Betts-Russell (Hydorphobic) 1731 187
4 Betts-Russell (Polar) 1318 234
5 Betts-Russell (Small) 1668 186
6 ALL class 3058 679
These motifs were discovered using MERCI software.input (20 and 400 respectively) irrespective of length of
the peptide. The SVM performed better on these feature
input as compared to binary vectors.
The performance of the SVM based models increases
after adding a feature of length along with compositional
vector. This may be co-related with the earlier report of
variation in affinity of MHC-peptide binding with the
variation in length of peptide [65]. The overhanging and
short peptides may be interfering with the ternary com-
plex of peptides-MHC-T cells. The exclusive motifs in
positive or negative dataset may be a major driver for
this differential behavior; these motifs were explored
using MERCI software. The motifs could be searched
using different classification of amino acids proposed in
the literature. The best classification is Betts-Russell with
hydrophobic root for our dataset. The top 100 motifs
searching under hydrophobic root of Betts-Russell clas-
sification are able to cover 532 of positive peptides and
1835 of negative peptides. The significance of motifs
could be estimated by its coverage and hydrophobic mo-
tifs are most commonly found in negative dataset.
Conclusion
In past large number of methods have been developed
for predicting MHC Class II binders or T-helper epi-
topes. In this study, an attempt has been made to classify
MHC class II binders based on their interleukin induc-
tion. We classify MHC class II binders in two categories;
first category of binders have ability to induce IFN-γ
where as second category of binders do not have ability
to induce IFN-γ. In order to discriminate two categories
of MHC binders, models have been developed using
various features of binders/peptide sequence that include
binary pattern, compositions, and motifs. Our models
were able to predict IFN-γ inducing peptide with high
precision, it mean it is possible to design peptide that
can induce IFN-γ. This study also indicates the prefer-
ence of certain MHC alleles and host strains/species to
skew the immune response to release interferon-gamma.
Table 4 Frequency of best motifs discovered using MERCI software in IFN-γ epitopes and Rest of cytokine inducing
epitopes from IFNgOnly dataset
Class of Motifs Found in IFN Epitopes Frequency Found in Rest-epitopes Frequency
None F-QP-Q 42 ANKIR 17
Koolman-Rohm R[basic]-R-[aliphatic] [neutral] 51 [neutral]K[aliphatic]RE 17
Betts-Russell (Hydorphobic) YR[aliphatic] 63 [hydrophobic]-N[hydrophobic][small]K-[R] 29
Betts-Russell (Polar) [polar]-YR[aliphatic] 53 [polar]-N[hydrophobic] [small]K-R 28
Betts-Russell (Small) small-YR[aliphatic] 54 PN[hydrophobic][small]-[positive]-[polar] 32
Negative sign (−) = represents the gaps at that position.
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in the advancement of computer aided vaccine design,
where researcher will be able of designing subunit vac-
cine with the desired immune response.
Webserver for designing IFN-γ inducing peptides
In order to serve scientific community, we developed a
web server IFNepitope using PHP, Perl, HTML and Java
scripts. This web server has three major modules called
Predict, Design and Scan. Module Predict allow users to
screen peptide library for predicting best IFN-γ inducing
epitopes. Design module of IFNepitope allows to iden-
tify minimum mutations required in a peptide to make
it IFN-γ inducing epitope. In Design module, first all
possible single residue mutation peptides are generated
then module predict IFN-γ inducing epitope in mutant
peptides. Similarly, Scan module predict antigenic or
IFN-γ inducing regions in an antigen. Overall this ser-
ver will be useful for researchers working in the field of
subunit vaccines.
Reviewers’ comments
Reviewer number1: Prof Kurt Blaser
Comment: The paper is interesting and helpful for
prediction and modulation of antigenic compounds and
generation of Type I cytokine pattern mainly in protect-
ive immunizations but also for allergen-immunotherapy.
The approach, although it is based on published experi-
mental observations, on theoretical mathematical models.
Thus it is difficult for me to evaluate the value and correct-
ness of these predictions. What to my mind is missing, are
some experimental data from human in vitro experiments,Table 5 The performance of SVM based models developed us
and without length of peptides on our main dataset
Input feature Descriptors Sens
Residue Composition 20 53.2
Residue Composition + Length 21 51.82
Dipeptide Composition 400 62.89
Dipeptide Composition + Length 401 66.5either with specific T cell clones or adequate PBMC cul-
tures that are stimulated with synthetic epitope- peptides
from these models. It is furthermore important that in
such experiments not only IFN-gamma but also a broader
pattern of the most important cytokines are measured, as
in many cases rather the ratio of IFN-gamma: other cyto-
kines (e.g. IL4) is important and not the absolute amount
of IFN-gamma.
Thus, I would strongly recommend to add such ex-
perimental data in order to prove the effectiveness of the
described models.
Response: We understand the reviewer’s concern about
the experimental validation of our model, but also its note-
worthy to mention here that we have developed this model
on experimentally proven dataset and evaluated using well-
established computational cross-validation approaches.
Quality of written English: Needs some language cor-
rections before being published.
Reviewer number2: Prof Laurence Eisenlohr
In this manuscript, Dhanda et al. describe their efforts
to develop tools to predict those MHC class II-binding
peptides that induce interferon-gamma production and
those that do not.
My concerns with this paper are as follows:
Comment: 1) The authors mined the peptide sequences
they analyzed from the Immune Epitope Database. My un-
derstanding (from communicating with IEDB staff) is that
those peptide sequences listed as “Negative” for cytokine
production have not been shown to bind any particular
MHC class II molecule (they are not “epitopes” per se, just
sequences that failed to elicit a T cell response with the
MHC class II restrictions that were tested). Thus, thereing residue (amino acid) and dipeptide composition with





Table 6 The performance of SVM based models developed using residue (amino acid) and dipeptide composition with
and without length of peptides on IFNgOnly dataset
Input feature Descriptors Sensitivity Specificity Accuracy MCC
Residue Composition 20 64.11 62.69 63.65 0.25
Residue Composition + Length 21 64.8 63.84 64.49 0.27
Dipeptide Composition 400 66.12 71.2 67.77 0.35
Dipeptide Composition + Length 401 65.31 71.9 67.45 0.35
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http://www.biology-direct.com/content/8/1/30may not be much basis for comparison; if they don’t bind
MHC class II to begin with, then of course they won’t
elicit interferon-gamma.
Response: We are thankful to the reviewer for this nice
comment. To answer this comment, we have created an-
other dataset “IFNgOnly”, which comprises the peptides,
which induce any other cytokine except interferon-
gamma. We have applied the same approach and achieved
the convincing results (Tables 3, 4, 6, 8 and 9).
Comment: 2) I imagine that most of these negative se-
quences are derived from overlapping15-16-mer peptide
libraries that were comprehensively screened for immuno-
genicity. This seems to be the likely explanation for the
skewing of negative sequences toward that size range.
Response: We do agree with the reviewer and there-
fore produced results with alternative negative dataset,
and observed no peptide length-wise preference for the
induction of interferon-gamma when compared with the
peptides that have induced other cytokine (except IFN-
gamma) in IFNgOnly dataset as shown in Figure 4.
Comment: 3) There is no consideration of species ori-
gin of the class II molecule or MHC polymorphism. A
negative peptide sequence for one animal or MHC allele
could be strongly positive in other conditions if they
were to be tested.
Response: This is important issue raised by reviewer,
we examine our main dataset again after comment. We
analyzed the IFN-gamma response with respect to MHC
alleles and found that there are 38 peptides in our data-
set that elicit IFN-gamma response in one host/MHC al-
lele and did not elicit such response with another host/
MHC-allele. We have considered these epitopes in our
positive examples.Table 7 The performance of hybrid models that combines Mo
residue and dipeptide composition with or without length on
Features Sensitivity
Residue Composition 70.74
Residue Composition + Length 74.84
Dipeptide Composition 74.79
Dipeptide Composition + Length 77.98
Dipeptide Composition + Length (10 fold) 78.49Comment: 4) As far as I can tell, there is also no con-
sideration of peptide binding register (where the peptide
is positioned with respect to the binding pockets).
Therefore, I do not know what to make of the reported
positional effects.
Response: We agree with the reviewer that positional
preference analyzed by us could not be correlated with
MHC groove because the positional information of pep-
tides. It is also fact that for most of the peptides/binders
position in MHC binding grove is not known. This is
first study and in future these points should be ad-
dressed when sufficient data is available.
Quality of written English: Needs some language cor-
rections before being published
Response: We have revised the manuscript and cor-
rections have been made to improve the English.
Reviewer number3: Dr Manabu Sugai
The authors have an idea to find ideal peptides to elicit
Th1 response for developing novel vaccination strategy.
To this end, they developed a webserver for predicting
IFN-gamma inducing peptides by analyzing the dataset
from IEDB.
Comment: The paper is interesting, and I think would
be of interest to readers of Biology Direct. However, the
validation of their program is not enough for providing
functional rationale to support their concept. Author’s
idea depends on the notion that the specific peptides
promote specific helper T cell differentiation. However,
such an idea is not easily accepted, because various cyto-
kines, but not TCR-signals, play dominant role in
instructing helper T cell differentiation.
Response: Thank you for this comment, but we would








Figure 9 The performance of various models developed in this study in form of ROC plots on our main dataset.
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http://www.biology-direct.com/content/8/1/30substitution of single amino acid in a peptide had skewed
the immune response from Th1 to Th2 or vice-versa
[49-52]. Therefore the notion of peptide based immune
modulation is existing in literature and we are develop-
ing a prediction model for designing the peptide that
have potential to induce IFN gamma and hope that this
model would be very useful in peptide-based vaccin-
ation and therapeutics.
Comment: On the other hands, IFN-gamma inducing
activities of the peptides were usually estimated as a mem-
ory reaction, indicated by the comments from IEDB.
Therefore, we can speculate that some peptides specific im-
mune reaction occurs specifically in Th1 skewed condition.
According to this notion, we can use IFN-gamma inducing
peptides as an adjuvant to induce memory reaction in vivo.
To validate this notion, the authors need to examine
whether other cytokine-inducing-peptides, such as IL4,
IL17, TGF-b etc., are selected or not by IFN-gamma
inducing-peptides finding program. If your program ex-
cludes other cytokine-inducing-peptides, your ideas are
supported partially and provide the meaning of your
program for future use. If other cytokine-inducing-
peptides are also included in the selected IFN-gammaTable 8 The performance of hybrid models that combines Mo
residue and dipeptide composition with or without length on
Features Sensitivity
Residue Composition 86.97
Residue Composition + Length 85.19
Dipeptide Composition 87.53
Dipeptide Composition + Length 87.31inducing-peptides, author’s concept is not correct or
program itself is incomplete.
Response: We are thankful to reviewers for providing
detail information on IFN-gamma inducing peptides.
Our aim in this study is to discriminate inducing and
non-inducing peptides. In order to address issue raised
by reviewer we developed models for discriminating
IFN-gamma and non-IFN-gamma (induce other cyto-
kines except IFN-gamma). First we created a dataset
called IFNgOnly contains IFN-gamma and other cyto-
kine inducing peptides. The performance of our models
on this IFNgOnly dataset is shown in Tables 3, 4, 6 and
8. As shown in result section our models were able to
discriminate peptide which induce IFN-gamma and pep-
tides that induce other cytokines.
Quality of written English: Acceptable
Responses to reviewer’s comments after revision
Reviewer number:2 Prof Laurence Eisenlohr
This paper by Dhanda and et al. proposes both length
and sequence biases for MHC class II presented peptides
that elicit interferon-gamma responses (vs. those that do
not). I remain skeptical about the conclusions in this







Table 9 Performance of SVM on IFNrandom dataset with
compositional features of residues
Descriptors Threshold Sen Spec Acc MCC
AA Composition 0 64.97 69.04 67 0.34
DP Composition 0.1 69.18 77.62 73.4 0.47
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http://www.biology-direct.com/content/8/1/30Comment: 1) the basis for lack of interferon produc-
tion. Are peptides that have been shown to bind to an
MHC class II molecule but not elicit any response
(“non-epitopes”) included in the analyses? This would be
problematic. In our hands essentially all epitopes elicit
some interferon-gamma response following natural virus
infection so the distribution of epitopes (3705 inducers
vs. 6728 non-inducers) is worrisome.
Response: Our main dataset contain 10,433 peptides ob-
tained from 17,752 IFN-gamma assays; 6,728 peptides do
not release IFN-gamma (as per IEDB) which we called
negative peptides in this study. We agree with reviewer that
all the MHC class II binders are not epitopes; thus negative
peptides in our main dataset may also include non-epitope.
In order to overcome this limitation, we created another
dataset called IFNgOnly, where negative peptides/epitopes
contain only those peptide that induce cytokine other than
IFN-gamma. In simple term negative peptides in IFNgOnly
are true non IFN-gamma inducing epitopes.
Comment: 2) inclusion/exclusion criteria. As an exer-
cise, I went to the IEDB and searched for all MHC class II
binders that do not elicit an interferon-gamma response. I
then randomly chose lysteriolysin O (LLO), residues 216-
227, described by Skoberne et al., 2002, J Immunol.,
169:1410-8. In fact, this epitope does elicit an interferon-
gamma response in BALB/c mice (because it is a CD4+ T
cell epitope in that strain) but does not elicit an interferon-
gamma response in C57Bl/6 mice (because it is not an epi-
tope in that strain). Thus, it is listed in both categories.
How did the authors deal with this? Exclude? Include in
both categories? Include in only one category? How many
other peptides in the database also fall into both categories?
Response: We followed IEDB recommendations, in
case multiple assays are performed to test a peptide, it is
considered positive even if a single assays shows positive.
There are 667 epitopes/peptides falling in both the cat-
egories and we have included them in our positive dataset.
Comment: 3) the peptide lengths that are entered into
the database.
Many epitopes are now identified via overlapping
15-mer libraries, with no subsequent attempts to map
the minimal epitope or the effects of flanking residues
due to the added expense. This seems to be the likely
reason for the predominance of peptides of that size
(Figure 2). In fact, the analysis can only be done with
peptides that have been stringently defined with respectto the minimal core and flanking sequence effects, a
much smaller set than was analyzed.
Many of the longer peptides may not have been
identified by the library method but by the previous
method of enzymatic digestion of antigen and in vitro
assay with a T cell line, clone or hybridoma, again with
no subsequent mapping of core and flanking sequences.
Also, the longer peptides may have been deduced in
mapping a known response, and this could be the
reason for bias toward interferon-gamma production in
this cohort.o There is no discussion of the bimodal
length distribution, which, for the reasons discussed,
may have a technical vs. biological basis.
Response: Our main dataset were created without con-
sidering the epitopic information’s. Most of the peptides in
our datasets are either ‘exact epitopes’ or ‘epitope contain-
ing region’ as per mentioned in IEDB database.
Comment: 4) how several other potential biasing fac-
tors, all of which can strongly influence both parameters
(length and sequence bias) were accounted for, including:
origin of the peptide (pathogen, self-protein, natural
sequence or variant, …)
host species
method of immunization (peptide, organism-
experimental infection, organism-natural infection,
adjuvant, …)
host strain (BALB/c vs. C57Bl/6-Type I vs. Type 2)
identity of the class II molecule. Some class II
molecules are over-represented in the database and this
alone could account for the deduced sequence
preferences.
Response: We do agree with the reviewer that the is-
sues related to host species, immunization protocol and
MHC alleles should also be considered, but this is the
first study to predict the immune response of a peptide
sequence. These limitations have to be addressed in fu-
ture research. In order to address this issue we have in-
vestigated our dataset and provided the insight in the
‘Examination of dataset’ paragraph of ‘Result’ section.
Quality of written English: Needs some language cor-
rections before being published.
Reviewer number:3 Dr Manabu Sugai
The revised manuscript from Dhanda et al. has been
significantly improved. This paper is acceptable now.
Quality of written English: Acceptable
Additional files
Additional file 1: Analysis of epitopes with respect to MHC allele,
host strain and source organism. There is 6 different sheets in this
excel file: (1) The distribution of peptides with respect to (w.r.t.) source
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http://www.biology-direct.com/content/8/1/30organisms in our main dataset. (2). The distribution of peptides w.r.t. host
strains in our main dataset. (3) The distribution of peptides w.r.t. MHC
alleles in our main dataset. (4) The distribution of peptides w.r.t. source
organism in our IFNgOnly dataset. (5) The distribution of peptides w.r.t.
host strains in our IFNgOnly dataset. (6) The distribution of peptides w.r.t.
MHC alleles in our IFNgOnly dataset.
Additional file 2: Performance of SVM light on 15 residues from
N or C terminal. Table S1. The performance of various features with
SVM light on 5 folds cross validation. Figure SF1. Variation in amino
acid residue composition of residue taken from 15 N-terminus.
Figure SF2. Variation in amino acid residue composition of residue
taken from 15 C-terminus.
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